Variant report
Variant | esv3370380 |
---|---|
Chromosome Location | chr3:20557997-20575540 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs534348484 | chr3:20558094-20558095 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs548758369 | chr3:20558116-20558117 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs147475988 | chr3:20558135-20558136 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs567688794 | chr3:20558172-20558173 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs663371 | chr3:20559407-20559408 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs192457318 | chr3:20559431-20559432 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs568725812 | chr3:20559457-20559458 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs528737557 | chr3:20559463-20559464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs533281353 | chr3:20559530-20559531 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs551657253 | chr3:20559630-20559631 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs79228540 | chr3:20559651-20559652 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs533969071 | chr3:20559783-20559784 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs182296235 | chr3:20559795-20559796 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs567729896 | chr3:20559847-20559848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs186911990 | chr3:20559852-20559853 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs556541699 | chr3:20559961-20559962 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs56845101 | chr3:20559983-20559984 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs566769479 | chr3:20560008-20560009 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs374288596 | chr3:20560037-20560038 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs372946070 | chr3:20560057-20560058 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs73821405 | chr3:20560200-20560201 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs572351052 | chr3:20560216-20560217 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs542790878 | chr3:20560265-20560266 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs191733387 | chr3:20560294-20560295 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs569423111 | chr3:20560325-20560326 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs538434657 | chr3:20560326-20560327 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs555214035 | chr3:20560336-20560337 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs113459583 | chr3:20560363-20560364 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs543945605 | chr3:20560397-20560398 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs370171814 | chr3:20560430-20560431 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs184038900 | chr3:20560463-20560464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs532753793 | chr3:20560478-20560479 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs551743080 | chr3:20560554-20560555 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs566772931 | chr3:20560573-20560574 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs55971226 | chr3:20560589-20560590 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs549213303 | chr3:20560614-20560615 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs367797809 | chr3:20560713-20560714 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs188353450 | chr3:20560734-20560735 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs140966627 | chr3:20560778-20560779 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs114572118 | chr3:20560784-20560785 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs552181125 | chr3:20560885-20560886 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs571654602 | chr3:20560949-20560950 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs538644068 | chr3:20560969-20560970 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs11716457 | chr3:20561048-20561049 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs572389110 | chr3:20561070-20561071 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs542878936 | chr3:20561072-20561073 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs34158362 | chr3:20561214-20561215 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs192811959 | chr3:20561220-20561221 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs185324332 | chr3:20561239-20561240 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs190349542 | chr3:20561242-20561243 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Breast cancer | 17133270 | CNVD |
Developmental delay | 21147756 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:20557200-20558200 | Enhancers | Liver | Liver |
2 | chr3:20557400-20558000 | Enhancers | Adipose Nuclei | Adipose |
3 | chr3:20559400-20569400 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr3:20565000-20565400 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
5 | chr3:20565000-20565400 | ZNF genes & repeats | Pancreas | Pancrea |
6 | chr3:20569000-20569800 | Enhancers | Fetal Stomach | stomach |
7 | chr3:20569000-20571200 | Enhancers | Fetal Intestine Small | intestine |
8 | chr3:20569200-20571200 | Enhancers | Fetal Intestine Large | intestine |
9 | chr3:20569400-20569600 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
10 | chr3:20569600-20570000 | Enhancers | Fetal Lung | lung |
11 | chr3:20569800-20570200 | Weak transcription | Fetal Stomach | stomach |
12 | chr3:20570000-20570400 | Weak transcription | Fetal Lung | lung |
13 | chr3:20570200-20571000 | Enhancers | Fetal Stomach | stomach |
14 | chr3:20570400-20571000 | Enhancers | Fetal Lung | lung |